Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0042 Transporter Info
Gene Name	ABCA4
Transporter Name	ATP-binding cassette sub-family A member 4
Gene ID	24
UniProt ID	P78363

Post-Translational Modification of This DT
Overview of ABCA4 Modification Sites with Functional and Structural Information
Sequence	M G F V R Q I Q L L L W K N W T L R K R Q K I R F V V E L V W P L S L F L V L I W L R N A N P L Y S H H E C H F P N K A M P S A G M L P W L Q G I F C N V N N P C F Q S P T P G E S P G I V S N Y N N S I L A R V Y R D F Q E L L M N A P E S Q H L G R I W T E L H I L S Q F M D T L R T H P E R I A G R G I R I R D I L K D E E T L T L F L I K N I G L S D S V V Y L L I N S Q V R P E Q F A H G V P D L A L K D I A C S E A L L E R F I I F S Q R R G A K T V R Y A L C S L S Q G T L Q W I E D T L Y A N V D F F K L F R V L P T L L D S R S Q G I N L R S W G G I L S D M S P R I Q E F I H R P S M Q D L L W V T R P L M Q N G G P E T F T K L M G I L S D L L C G Y P E G G G S R V L S F N W Y E D N N Y K A F L G I D S T R K D P I Y S Y D R R T T S F C N A L I Q S L E S N P L T K I A W R A A K P L L M G K I L Y T P D S P A A R R I L K N A N S T F E E L E H V R K L V K A W E E V G P Q I W Y F F D N S T Q M N M I R D T L G N P T V K D F L N R Q L G E E G I T A E A I L N F L Y K G P R E S Q A D D M A N F D W R D I F N I T D R T L R L V N Q Y L E C L V L D K F E S Y N D E T Q L T Q R A L S L L E E N M F W A G V V F P D M Y P W T S S L P P H V K Y K I R M D I D V V E K T N K I K D R Y W D S G P R A D P V E D F R Y I W G G F A Y L Q D M V E Q G I T R S Q V Q A E A P V G I Y L Q Q M P Y P C F V D D S F M I I L N R C F P I F M V L A W I Y S V S M T V K S I V L E K E L R L K E T L K N Q G V S N A V I W C T W F L D S F S I M S M S I F L L T I F I M H G R I L H Y S D P F I L F L F L L A F S T A T I M L C F L L S T F F S K A S L A A A C S G V I Y F T L Y L P H I L C F A W Q D R M T A E L K K A V S L L S P V A F G F G T E Y L V R F E E Q G L G L Q W S N I G N S P T E G D E F S F L L S M Q M M L L D A A V Y G L L A W Y L D Q V F P G D Y G T P L P W Y F L L Q E S Y W L G G E G C S T R E E R A L E K T E P L T E E T E D P E H P E G I H D S F F E R E H P G W V P G V C V K N L V K I F E P C G R P A V D R L N I T F Y E N Q I T A F L G H N G A G K T T T L S I L T G L L P P T S G T V L V G G R D I E T S L D A V R Q S L G M C P Q H N I L F H H L T V A E H M L F Y A Q L K G K S Q E E A Q L E M E A M L E D T G L H H K R N E E A Q D L S G G M Q R K L S V A I A F V G D A K V V I L D E P T S G V D P Y S R R S I W D L L L K Y R S G R T I I M S T H H M D E A D L L G D R I A I I A Q G R L Y C S G T P L F L K N C F G T G L Y L T L V R K M K N I Q S Q R K G S E G T C S C S S K G F S T T C P A H V D D L T P E Q V L D G D V N E L M D V V L H H V P E A K L V E C I G Q E L I F L L P N K N F K H R A Y A S L F R E L E E T L A D L G L S S F G I S D T P L E E I F L K V T E D S D S G P L F A G G A Q Q K R E N V N P R H P C L G P R E K A G Q T P Q D S N V C S P G A P A A H P E G Q P P P E P E C P G P Q L N T G T Q L V L Q H V Q A L L V K R F Q H T I R S H K D F L A Q I V L P A T F V F L A L M L S I V I P P F G E Y P A L T L H P W I Y G Q Q Y T F F S M D E P G S E Q F T V L A D V L L N K P G F G N R C L K E G W L P E Y P C G N S T P W K T P S V S P N I T Q L F Q K Q K W T Q V N P S P S C R C S T R E K L T M L P E C P E G A G G L P P P Q R T Q R S T E I L Q D L T D R N I S D F L V K T Y P A L I R S S L K S K F W V N E Q R Y G G I S I G G K L P V V P I T G E A L V G F L S D L G R I M N V S G G P I T R E A S K E I P D F L K H L E T E D N I K V W F N N K G W H A L V S F L N V A H N A I L R A S L P K D R S P E E Y G I T V I S Q P L N L T K E Q L S E I T V L T T S V D A V V A I C V I F S M S F V P A S F V L Y L I Q E R V N K S K H L Q F I S G V S P T T Y W V T N F L W D I M N Y S V S A G L V V G I F I G F Q K K A Y T S P E N L P A L V A L L L L Y G W A V I P M M Y P A S F L F D V P S T A Y V A L S C A N L F I G I N S S A I T F I L E L F E N N R T L L R F N A V L R K L L I V F P H F C L G R G L I D L A L S Q A V T D V Y A R F G E E H S A N P F H W D L I G K N L F A M V V E G V V Y F L L T L L V Q R H F F L S Q W I A E P T K E P I V D E D D D V A E E R Q R I I T G G N K T D I L R L H E L T K I Y P G T S S P A V D R L C V G V R P G E C F G L L G V N G A G K T T T F K M L T G D T T V T S G D A T V A G K S I L T N I S E V H Q N M G Y C P Q F D A I D E L L T G R E H L Y L Y A R L R G V P A E E I E K V A N W S I K S L G L T V Y A D C L A G T Y S G G N K R K L S T A I A L I G C P P L V L L D E P T T G M D P Q A R R M L W N V I V S I I R E G R A V V L T S H S M E E C E A L C T R L A I M V K G A F R C M G T I Q H L K S K F G D G Y I V T M K I K S P K D D L L P D L N P V E Q F F Q G N F P G S V Q R E R H Y N M L Q F Q V S S S S L A R I F Q L L L S H K D S L L I E E Y S V T Q T T L D Q V F V N F A K Q Q T E S H D L P L H P R A A G A S R Q A Q D
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Essential for the proper folding of ABCA4			[1] , [2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	98
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 98 have been reported to be essential for its proper protein folding.
PTM Phenomenon 2	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	415
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 415 have been reported to be essential for its proper protein folding.
PTM Phenomenon 3	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	444
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 444 have been reported to be essential for its proper protein folding.
PTM Phenomenon 4	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	504
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 504 have been reported to be essential for its proper protein folding.
PTM Phenomenon 5	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	1469
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 1469 have been reported to be essential for its proper protein folding.
PTM Phenomenon 6	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	1529
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 1529 have been reported to be essential for its proper protein folding.
PTM Phenomenon 7	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	1588
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 1588 have been reported to be essential for its proper protein folding.
PTM Phenomenon 8	Essential for the proper folding of ABCA4			[2]
Role of PTM	Protein Stability
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Asparagine	Modified Location	1662
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA4 Asparagine 1662 have been reported to be essential for its proper protein folding.
Phosphorylation
Serine	16 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Significantly decreased the activity of the transporter			[3]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Serine	Modified Location	1185
Modified State	Serine to Alanine mutation
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-7) cells; Human Embryonic Kidney 293T (HEK-293T) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ABCA4 Serine 1185 (i.e. Serine to Alanine mutation) have been reported to significantly decrease its transport activity.
PTM Phenomenon 2	Decreasing the activity of ABCA4			[3]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Serine	Modified Location	1317
Modified State	Serine to Alanine mutation
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-7) cells; Human Embryonic Kidney 293T (HEK-293T) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ABCA4 Serine 1317 (i.e. Serine to Alanine mutation) have been reported to decrease its transport activity.
PTM Phenomenon 3	Have the potential to influence ABCA4			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 133 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA4			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	278
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 278 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCA4			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1090
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1090 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCA4			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1096
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1096 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCA4			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1181
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1181 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCA4			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1282
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1282 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCA4			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1531
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1531 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1544
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1544 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1545
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1545 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1648
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1648 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1658
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 1658 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCA4			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2057
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 2057 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCA4			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2115
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 2115 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCA4			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2173
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Serine 2173 has the potential to affect its expression or activity.
Threonine	16 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Leading to ABCA4 misfolding and degradation			[3]
Role of PTM	Promoting Degradation
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Threonine	Modified Location	901
Modified State	Threonine to Alanine mutation
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-7) cells; Human Embryonic Kidney 293T (HEK-293T) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ABCA4 Threonine 901 (i.e. Threonine to Alanine mutation) have been reported to result in its protein misfolding and degradation.
PTM Phenomenon 2	Significantly decreased the activity of the transporter			[3]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Retinylidene-phosphatidylethanolamine (N-retinylidene-PE)	Results for Drug	Affecting the inward transport of retinylidene-phosphatidylethanolamine (N-retinylidene-PE)
Modified Residue	Threonine	Modified Location	1313
Modified State	Threonine to Alanine mutation
Experimental Material(s)	African green monkey kidney fibroblast-like (COS-7) cells; Human Embryonic Kidney 293T (HEK-293T) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ABCA4 Threonine 1313 (i.e. Threonine to Alanine mutation) have been reported to significantly decrease its transport activity.
PTM Phenomenon 3	Have the potential to influence ABCA4			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	138
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 138 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA4			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	620
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 620 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCA4			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1089
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1089 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCA4			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1176 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCA4			[8] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1537
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1537 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCA4			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1595
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1595 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1655
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1655 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1664
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1664 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCA4			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1930
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1930 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCA4			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1986
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1986 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCA4			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1992
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 1992 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCA4			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	2061
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 2061 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCA4			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	2153
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 2153 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCA4			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	2168
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Threonine 2168 has the potential to affect its expression or activity.
Tyrosine	12 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA4			[16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	400
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 400 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	569
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 569 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCA4			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	603
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 603 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA4			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	610
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 610 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCA4			[6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1095
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 1095 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCA4			[8] , [12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1538
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 1538 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCA4			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1652
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 1652 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCA4			[17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2034
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 2034 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCA4			[17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2036
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 2036 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCA4			[9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2063
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 2063 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCA4			[10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2165
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 2165 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCA4			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA4 Tyrosine 2203 has the potential to affect its expression or activity.

References
1	The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. Adv Exp Med Biol. 2010;703:105-25.
2	Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J Biol Chem. 2001 Jun 29;276(26):23539-46.
3	Posttranslational modifications of the photoreceptor-specific ABC transporter ABCA4. Biochemistry. 2011 Aug 16;50(32):6855-66.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCA4_HUMAN)
5	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
6	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
7	Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
8	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
9	Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 2012 May 15;72(10):2501-11.
10	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
11	FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides. J Proteome Res. 2015 Dec 4;14(12):5077-87.
12	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
13	Distribution and severity of hypoxic-ischaemic lesions on brain MRI following therapeutic cooling: selective head versus whole body cooling. Arch Dis Child Fetal Neonatal Ed. 2012 Sep;97(5):F335-9.
14	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
15	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
16	Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
17	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
18	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
19	Behavioral correlates for the MMPI standard F scale and for a modified F scale for black and white psychiatric patients. J Consult Clin Psychol. 1981 Jun;49(3):455-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence